Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent.
about
Targeted nanotechnology for cancer imaging.Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsMolecular imaging of inflammation in atherosclerosis.Characterization of a lanthanide complex encapsulated with MRI contrast agents into liposomes for biosensor imaging of redundant deviation in shifts (BIRDS).ICAM-1-Targeted Liposomes Loaded with Liver X Receptor Agonists Suppress PDGF-Induced Proliferation of Vascular Smooth Muscle Cells.Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin.The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose.Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Interaction between drug delivery vehicles and cells under the effect of shear stress.Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood.Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent.Particle Targeting in Complex Biological Media.Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective.
P2860
Q27010317-EE78F6D3-8443-4771-A1A2-EA77394E63AAQ27027613-E1382E7A-2CCE-414E-8F2A-E655DF434B2BQ30446268-40B818FF-D11E-4BE6-BC0A-2B837CC1F8D0Q30859122-1A148DD9-953F-484D-BEE9-A8155F9D711DQ33633564-98CC14E5-E506-461D-8102-0906F7FA3B72Q33739996-FB109928-06B0-47AC-B632-8D215988BC51Q34323203-40F7D3B0-0145-4FB5-A016-DEB090BDE725Q34736942-B07E6495-B3D1-4258-A6B3-E4B5E02DDB8BQ36598388-0E72A4BA-1037-4517-82B0-401BA9144A0DQ38094125-34DC6508-A020-43FC-8013-D8DB437E1632Q38548252-763AD1A3-3779-4C97-94CB-F09986D7BFFBQ38560337-1E8E5504-34D5-4B53-89D6-AFD258726C5AQ38757789-DDD2A387-042B-4D3F-AB7B-39ED523243F9Q38957484-645A6CA3-EB4D-4997-A22F-36B297DF0592Q39196364-DDF0C8F1-7722-41B5-8597-ACF58ACDAA0CQ47794249-DF5CDCBE-953A-45AF-89BE-8EFBEF8BEDC1Q55035936-F8B36562-DF0E-4972-9228-3CF5D742F58C
P2860
Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@en
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@nl
type
label
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@en
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@nl
prefLabel
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@en
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@nl
P2093
P2860
P356
P1476
Targeting of ICAM-1 on vascula ...... l Gd-based MRI contrast agent.
@en
P2093
Daniel G Molin
Gustav J Strijkers
Igor Jacobs
Leonie E M Paulis
Lucas W E Starmans
Nynke M van den Akker
Tessa Geelen
P2860
P2888
P356
10.1186/1477-3155-10-25
P577
2012-06-20T00:00:00Z
P5875
P6179
1051931935